日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk

良性前列腺增生和前列腺炎对前列腺癌风险的协同作用

Hung, S-C; Lai, S-W; Tsai, P-Y; Chen, P-C; Wu, H-C; Lin, W-H; Sung, F-C

BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML.

BPR1J-097 是一种新型 FLT3 激酶抑制剂,对 AML 具有强大的抑制活性

Lin W-H, Jiaang W-T, Chen C-W, Yen K-J, Hsieh S-Y, Yen S-C, Chen C-P, Chang K-Y, Chang C-Y, Chang T-Y, Huang Y-L, Yeh T-K, Chao Y-S, Chen C-T, Hsu J T-A

SLURP1 mutation-impaired T-cell activation in a family with mal de Meleda

患有梅毒症的家族中 SLURP1 突变导致 T 细胞活化受损

J-W Tjiu, P-J Lin, W-H Wu, Y-P Cheng, H-C Chiu, H-Y Thong, B-L Chiang, W-S Yang, S-H Jee

Surfactant replacement therapy

表面活性剂替代疗法

Kresch, M J; Lin, W H; Thrall, R S